eli lilly weight loss drug news - Search News

Weight-Loss Drug Receives Approval

Hosted on MSN · 1h

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

Popular Weight Loss Drug Zepbound Gains FDA Approval to Treat Sleep Apnea

The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.

Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.

9hon MSN

Does This News From the FDA Make Eli Lilly a Buy for 2025?

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

Bloomberg L.P. on MSN4d

Lilly’s US Weight-Loss Drug Shortage Ends, Curtailing Copies

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which ...

5hon MSN

Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark.

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results